Proteomic and functional characterisation of platelet microparticle size classes

Thrombosis and Haemostasis

Volumn 102, Issue 4, 2009, Pages 711-718

  Dean, William L ^a   Lee, Menq J ^a   Cummins, Timothy D ^a   Schultz, David J ^b   Powell, David W ^a   Dean, Bill ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Blood platelets; Microparticles; Platelet activation; Proteomics; Sphingosine 1 phosphate; Transendothelial cell electrical resistance

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; GROWTH FACTOR; MEMBRANE RECEPTOR; SPHINGOSINE 1 PHOSPHATE;

ARTICLE; CELL FUNCTION; CELL SIZE; CONTROLLED STUDY; HUMAN; PLATELET MICROPARTICLE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; THROMBOCYTE FUNCTION;

BLOOD COAGULATION; BLOOD PLATELETS; CELL FRACTIONATION; CELL-DERIVED MICROPARTICLES; CELLS, CULTURED; ELECTRIC IMPEDANCE; ENDOTHELIAL CELLS; FEMALE; HEMOSTASIS; HUMANS; MASS SPECTROMETRY; ORGANELLE SIZE; PREGNANCY; PROTEOMICS; UMBILICAL CORD;

EID: 70449477153     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH09-04-243     Document Type: Article

References (44)

1. Wolf P. The nature and significance of platelet products in human plasma. Br J Haematol. 1967; 13: 269-288.
2. Heijnen HF, Schiel, AE, Fijnheer R, et al. Activated platelets release two types of membrane vesicles; microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and a-granules. Blood. 1999; 94: 3791-3799.
3. Reininger AJ, Heijnen HF, Schumann H, et al. Mechanism of platelet adhesion to vonWillebrand factor and microparticle formation under high shear stress. Blood. 2006; 107: 3537-3545
4. Denzer K, Kleijmeer MJ, Heijnen HFG, et al. Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J Cell Sci. 2000; 113: 3365-3374 (Pubitemid 30831289)
5. Piccin A, Murphy WG, Smith OP. Circulating microparticles: pathophysiology and clinical implications. Blood Rev. 2007; 21: 157-171. (Pubitemid 46529055)
6. Flaumenhaft R, James R, Dilks, JR, et al. Mega-karyocyte- derived microparticles: Direct visualization and distinction from platelet-derived microparticles. Blood. 2009; 113: 1112-1121
7. Smalley DM, Root KE, Cho HJ, et al. Proteomic discovery of 21 proteins expressed in human plasma-derived but not platelet-derived microparticles. Thromb Haemost 2007; 97: 67-80.
8. Jin M, Drwal G, Bourgeois T, et al. Distinct proteome features of plasma microparticles. Proteomics. 2005; 5: 1940-1952. (Pubitemid 40686238)
9. Gracia BA, Smalley DM, Cho H, et al. The platelet microparticle proteome. J Proteome Res. 2005; 4: 1516-1521.
10. Perez-Pujol S, Marker PH, Key NS. Platelet microparticles are heterogeneous and highly dependent on the activation mechanism: studies using a new digital flow cytometer. Cytometry A. 2007; 71: 38-45. (Pubitemid 46207382)
11. Biro E, Akkerman JW, Hoek FJ, et al. The phospholipid composition and cholesterol content of platelet derived microparticles: a comparison with platelet membrane fractions. Thromb Haemost. 2005; 3: 2754-2763. (Pubitemid 41819805)
12. Sims PJ, Wiedmer T, Esmon CT, et al. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane: studies in Scott syndrome, an isolated defect in platelet procoagulent actvitity. J Biol Chem. 1989; 264: 17049-17057 (Pubitemid 19255533)
13. Berckmans RJ, Nieuwland R, Tak PP, et al. Cell-derived microparticles in synovial fluid from inflamed arthritic joints support coagulation exclusively via a factor VII-dependent mechanism. Arthritis Rheum. 2002; 46: 2857-2866. (Pubitemid 35315876)
14. Nieuwland R, Berckmans RJ, Rotteveel-Eijkman RC, et al. Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulent. Circulation. 1997; 96: 3534-3541. (Pubitemid 27513430)
15. Sinauridze EI, Kireev DA, Popenko NY, et al. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets. Thromb Haemost. 2007; 97: 425-434.
16. Merten M, Pakala R, Thiagarajan P, Benedict CR. Platelet microparticles promote platelet interaction with subendothelial matrix in a glycoprotein IIb-IIIa-dependent mechanism. Circulation. 1999.; 99: 2577-2582.
17. Dachary-Prigent J, Pasquet JM, Fressinaud E, Toti F, Freyssinet JM, Nurden AT. Aminophospholipid exposure, microvesicularization and abnormal protein tyrosine phosphorylation in the platelets of a patient with Scott syndrome: a study using physiologic agonists and local anaesthetics.Br J Haematol. 1997;99:959-967
18. Toti F, Satta N, Fressinaud E, et al. Scott syndrome, characterized by impaired transmembrane migration of procoagulent phosphatidylserine and hemorrhagic complications, is an inherited disorder. Blood. 1996; 87: 1409-1415 (Pubitemid 26056904)
19. Kim HK, Song KS, Chung JH, et al. Platelet micro-particles induce angiogenesis in vitro. Br J Haematol. 2004; 124: 376-384.
20. Weber A, Koppen HO, Schror K. Platelet-derived microparticles stimuilate coronary artery smooth muscle cell mitogenesis by a PDGF-independent mechanism. Thromb Res. 2000; 98: 461-466 (Pubitemid 30319319)
21. Boulanger CM, Amabile N, Tedgui A. Circulating Microparticles: a potential prognosis marker for atherosclerotic vascular disease. Hypertension. 2006; 48: 180-186
22. Preston RA, Jy W, Jimenez JJ, et al. Effects of severe hypertension on endothelial and platelet microparticles. Hypertension. 2003; 41: 211-217. (Pubitemid 36204891)
23. van der Zee PM, Biró E, Ko Y, et al. P-Selectin and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction. Clin Chem. 2006; 52: 657-664.
24. Diehl P, Nagy F, Sossong V, et al. Increased levels of circulating microparticles in patients with severe aortic valve stenosis. Thromb Haemost. 2008; 99: 711-719. (Pubitemid 351694227)
25. Barry OP, Pratico D, Lawson JA, et al. Transcellular activiation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J Clin Invest. 1997; 99: 2118-2127. (Pubitemid 27203768)
26. Pfister SL. Role of Platelet Microparticles in the production of thromboxane by rabbit pulmonary artery. Hypertension. 2004; 43: 428-433.
27. Barry OP, Kazanietz MG, Praticò D, et al. Arachidonic acid in platelet microparticles up-regulates cyclooxygenase-2-dependent prostaglandin formation via a protein kinaseC/mitogen-activated protein kinase- dependent pathway. J Biol Chem. 1999; 274: 7545-7556. (Pubitemid 129505051)
28. Alvarex SE, Milstien S, Spiegel S. Acutocrine and paracrine roles of sphingosine-1-phosphate. Trends Endocrinol Metab. 2007; 18: 300-307
29. Sano T, Baker D, Virag T, et al. Multiple Mechanisms linked to platelet activation results in lysophosphatidic acid and sphingosine-1-phosphate generaion in blood. J Biol Chem. 2002; 277: 21197-21206. (Pubitemid 34952255)
30. Yatomi Y, Ohmori T, Rile G, et al. Sphingosine- 1-phosphate as a major bioactive lysophospholipid that is released from platelets and interacts with endothelial cells. Blood. 2000; 96: 3431-3438. (Pubitemid 30836322)
31. Kobayashi N, Nishi T, Hirata T, et al. Sphingosine- 1-phosphate is released from the cytosol of rat platelets in a carrier-mediated manner. J Lipid Res. 2006; 47: 614-621. (Pubitemid 43345602)
32. 2+-ATPase associates with the actin cytoskeleton via CLP36 in human platelets. Thromb Haemost. 2007; 87: 587-597
33. Bartlett GR Phosphorus Assay in Column Chromatography. J Biol Chem. 1959; 234: 466-468.
34. Powell DW, Merchant ML, Link AJ. Discovery of regulatory molecular events and biomarkers using 2D capillary chromatography and mass spectrometry. Expert Rev Proteomics. 2006; 3: 63-74
35. Powell DW, Weaver CM, Jennings JL, et al. Cluster analysis of mass spectrometry data reveals a novel component of SAGA. Mol Cell Biol. 2004; 24: 7249-7259.
36. Yoon HT, Yoo HS, Shin BK, et al. Improved fluorescent determination method of cellular sphingoid bases in high-performance liquid chromatography. Arch Pharm Res. 1999; 22: 294-299.
37. Caligan TB, Peters K, Ou J, et al. A high-performance liquid chromatographic method to measure sphingosine-1-phosphate and related compounds from sphingosine kinase assays and other biological samples. Anal Biochem. 2000; 281: 36-44. (Pubitemid 30324339)
38. Kundu SK, Heilmann EJ, Sio R, et al. Description of an in vitro platelet function analyzer, PFA-100. Semin Thromb Hemost. 1995; 21: 106-112.
39. Heilmann EJ, Kundu SK, Sio R, et al. Comparison of four commercial citrate blood collection systems for platelet function analysis by the PFA-100 system. Thromb Res. 1997; 87: 159-164 (Pubitemid 27333273)
40. Keese CR, Wegener J, Walker SR, et al. Electrical wound-healing assay for cells in vitro. Proc Natl Acad Sci USA. 2001; 101: 1554-1559. (Pubitemid 38234193)
41. Lee JF, Zeng Q, Ozaki H,, et al. Dual roles of tight junction-associated protein, zonula occuledens-1, in sphingosine 1 phosphate-mediated endothelial chemo-taxis and barrier integrity. J Biol Chem. 2006; 281: 29190-29200 (Pubitemid 44507063)
42. Guidotti, G. Membrane Proteins. Annu Re. Biochem. 1972; 41: 731-752.
43. Davis MD, Clemens JJ, Macdonald TL, et al. Sphingosine-1-phosphate analogs as receptor antagonists. J Biol Chem. 2005; 280: 9833-9841.
44. Moebius J, Zahedi RP, Lewandrowski U, et al. The human platelet membrane proteome reveals several new potential membrane proteins. Mol Cell Prot. 2005; 4: 1754-1761. (Pubitemid 41749268)